LATEST NEWS February 21 2023 UBI launches another new product: Acetic Acid Test for Sentia January 30 2023 UBI launches new product: Fructose Test for Sentia January 23 2023 UBI completes Xprecia Prime clinical trial in USA January 11 2023 UBI’s Cancer Biomarker work gets published by American Chemical Society Journal “ACS Sensors” and is selected as “Front Cover” July 29 2022 Sentia new distribution deals in Europe and Glucose Test launch April 19 2022 Tn Antigen Peter Mac Development Clinical Study Results February 28 2022 Regulatory Approval to sell Xprecia PrimeTM in 32 countries in Europe January 18 2022 UBI launches new Sentia Malic Acid Test December 24 2021 UBI Signs new technology licensing deal to commercialise SARS-CoV-2 N- Protein test November 11 2021 UBI signs Master collaboration Agreement with Mayo Clinic October 4 2021 UBI signs major French distribution deal September 20 2021 UBI partners with world leader for cancer biosensor trials Page 1 Page 2 Page 3 … Page 6 Next »
